These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26600904)

  • 1. Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa.
    d'Elia A; Evans D; McNamara L; Berhanu R; Sanne I; Lönnermark E
    Pan Afr Med J; 2015; 22():4. PubMed ID: 26600904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South Africa.
    Kerkhoff AD; Longley N; Kelly N; Cross A; Vogt M; Wood R; Hermans S; Lawn SD; Harrison TS
    BMC Infect Dis; 2020 Jul; 20(1):555. PubMed ID: 32736601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    AIDS; 2012 Aug; 26(13):1635-43. PubMed ID: 22555166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.
    Lawn SD; Kerkhoff AD; Burton R; Schutz C; Boulle A; Vogt M; Gupta-Wright A; Nicol MP; Meintjes G
    BMC Med; 2017 Mar; 15(1):67. PubMed ID: 28320384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis.
    Drain PK; Losina E; Coleman SM; Giddy J; Ross D; Katz JN; Bassett IV
    BMC Pulm Med; 2016 Nov; 16(1):147. PubMed ID: 27842535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H; Mathabire Rucker SC; Cossa L; Bastard M; Amoros I; Manhiça I; Mbendera K; Telnov A; Szumilin E; Sanchez-Padilla E; Molfino L
    PLoS Med; 2019 Apr; 16(4):e1002792. PubMed ID: 31039161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.
    Thit SS; Aung NM; Htet ZW; Boyd MA; Saw HA; Anstey NM; Kyi TT; Cooper DA; Kyi MM; Hanson J
    BMC Med; 2017 Aug; 15(1):145. PubMed ID: 28774293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.
    Drain PK; Gounder L; Grobler A; Sahid F; Bassett IV; Moosa MY
    BMJ Open; 2015 Apr; 5(4):e006833. PubMed ID: 25877271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosis.
    Kerkhoff AD; Wood R; Vogt M; Lawn SD
    PLoS One; 2014; 9(7):e103285. PubMed ID: 25075867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study.
    Drain PK; Losina E; Coleman SM; Giddy J; Ross D; Katz JN; Walensky RP; Freedberg KA; Bassett IV
    BMC Infect Dis; 2014 Feb; 14():110. PubMed ID: 24571362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of urine lipoarabinomannan (LAM) in diagnosing tuberculosis and predicting mortality with and without HIV: prospective TB cohort from the Thailand Big City TB Research Network.
    Suwanpimolkul G; Kawkitinarong K; Manosuthi W; Sophonphan J; Gatechompol S; Ohata PJ; Ubolyam S; Iampornsin T; Katerattanakul P; Avihingsanon A; Ruxrungtham K
    Int J Infect Dis; 2017 Jun; 59():96-102. PubMed ID: 28457751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome.
    Conesa-Botella A; Loembé MM; Manabe YC; Worodria W; Mazakpwe D; Luzinda K; Mayanja-Kizza H; Miri M; Mbabazi O; Koole O; Kestens L; Colebunders R;
    J Acquir Immune Defic Syndr; 2011 Dec; 58(5):463-8. PubMed ID: 21963941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.
    Lawn SD; Edwards DJ; Kranzer K; Vogt M; Bekker LG; Wood R
    AIDS; 2009 Sep; 23(14):1875-80. PubMed ID: 20108382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe.
    Zijenah LS; Kadzirange G; Bandason T; Chipiti MM; Gwambiwa B; Makoga F; Chungu P; Kaguru P; Dheda K
    BMC Infect Dis; 2016 Jan; 16():20. PubMed ID: 26797499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.
    Peter JG; Zijenah LS; Chanda D; Clowes P; Lesosky M; Gina P; Mehta N; Calligaro G; Lombard CJ; Kadzirange G; Bandason T; Chansa A; Liusha N; Mangu C; Mtafya B; Msila H; Rachow A; Hoelscher M; Mwaba P; Theron G; Dheda K
    Lancet; 2016 Mar; 387(10024):1187-97. PubMed ID: 26970721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
    Gupta-Wright A; Corbett EL; Wilson D; van Oosterhout JJ; Dheda K; Huerga H; Peter J; Bonnet M; Alufandika-Moyo M; Grint D; Lawn SD; Fielding K
    PLoS Med; 2019 Apr; 16(4):e1002776. PubMed ID: 30951533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Accuracy of Lateral Flow Urine LAM Assay for TB Screening of Adults with Advanced Immunosuppression Attending Routine HIV Care in South Africa.
    Hanifa Y; Fielding KL; Chihota VN; Adonis L; Charalambous S; Karstaedt A; McCarthy K; Nicol MP; Ndlovu NT; Sahid F; Churchyard GJ; Grant AD
    PLoS One; 2016; 11(6):e0156866. PubMed ID: 27271432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of point-of-care lateral flow urine lipoarabinomannan antigen testing in HIV-positive adults in South Africa.
    Mukora R; Tlali M; Monkwe S; Charalambous S; Karat AS; Fielding KL; Grant AD; Vassall A
    Int J Tuberc Lung Dis; 2018 Sep; 22(9):1082-1087. PubMed ID: 30092876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.
    Nakiyingi L; Nonyane BA; Ssengooba W; Kirenga BJ; Nakanjako D; Lubega G; Byakika-Kibwika P; Joloba ML; Ellner JJ; Dorman SE; Mayanja-Kizza H; Manabe YC
    PLoS One; 2015; 10(7):e0133756. PubMed ID: 26222142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.